Prudential Financial’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Sell |
16,878
-21,765
| -56% | -$304K | ﹤0.01% | 2163 |
|
|
2025
Q1 | $525K | Sell |
38,643
-71,950
| -65% | -$978K | ﹤0.01% | 1820 |
|
|
2024
Q4 | $2.25M | Sell |
110,593
-6,800
| -6% | -$139K | ﹤0.01% | 1245 |
|
|
2024
Q3 | $3.42M | Buy |
117,393
+650
| +0.6% | +$18.9K | ﹤0.01% | 1180 |
|
|
2024
Q2 | $2.71M | Buy |
116,743
+36,314
| +45% | +$843K | ﹤0.01% | 1241 |
|
|
2024
Q1 | $1.65M | Sell |
80,429
-815
| -1% | -$16.7K | ﹤0.01% | 1557 |
|
|
2023
Q4 | $1.74M | Sell |
81,244
-72,584
| -47% | -$1.56M | ﹤0.01% | 1521 |
|
|
2023
Q3 | $3.17M | Buy |
153,828
+29,506
| +24% | +$609K | 0.01% | 1113 |
|
|
2023
Q2 | $3.67M | Buy |
124,322
+115,142
| +1,254% | +$3.4M | 0.01% | 1056 |
|
|
2023
Q1 | $287K | Sell |
9,180
-6
| -0.1% | -$187 | ﹤0.01% | 2279 |
|
|
2022
Q4 | $255K | Buy |
9,186
+897
| +11% | +$24.9K | ﹤0.01% | 2319 |
|
|
2022
Q3 | $243K | Buy |
8,289
+54
| +0.7% | +$1.58K | ﹤0.01% | 2395 |
|
|
2022
Q2 | $238K | Sell |
8,235
-12,518
| -60% | -$362K | ﹤0.01% | 2417 |
|
|
2022
Q1 | $667K | Sell |
20,753
-195,048
| -90% | -$6.27M | ﹤0.01% | 2066 |
|
|
2021
Q4 | $9.71M | Buy |
215,801
+28,339
| +15% | +$1.27M | 0.01% | 736 |
|
|
2021
Q3 | $9.46M | Sell |
187,462
-32,552
| -15% | -$1.64M | 0.01% | 753 |
|
|
2021
Q2 | $17.3M | Buy |
220,014
+32,070
| +17% | +$2.52M | 0.02% | 570 |
|
|
2021
Q1 | $10.7M | Buy |
187,944
+98,225
| +109% | +$5.61M | 0.02% | 737 |
|
|
2020
Q4 | $7.52M | Buy |
89,719
+55,914
| +165% | +$4.68M | 0.01% | 852 |
|
|
2020
Q3 | $1.21M | Buy |
+33,805
| New | +$1.21M | ﹤0.01% | 1550 |
|